Antiangiogenic therapy and immune checkpoint blockade go hand in hand.

ABSTRACT:

SUBMITTER: Campesato LF 

PROVIDER: S-EPMC5750272 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature